Abstract

BackgroundSelective reporting is included as a core domain of Cochrane’s tool for assessing risk of bias in randomised trials. There has been no evaluation of review authors’ use of this domain. We aimed to evaluate assessments of selective reporting in a cross-section of Cochrane reviews and to outline areas for improvement.MethodsWe obtained data on selective reporting judgements for 8434 studies included in 586 Cochrane reviews published from issue 1–8, 2015. One author classified the reasons for judgements of high risk of selective reporting bias. We randomly selected 100 reviews with at least one trial rated at high risk of outcome non-reporting bias (non-/partial reporting of an outcome on the basis of its results). One author recorded whether the authors of these reviews incorporated the selective reporting assessment when interpreting results.ResultsOf the 8434 studies, 1055 (13 %) were rated at high risk of bias on the selective reporting domain. The most common reason was concern about outcome non-reporting bias. Few studies were rated at high risk because of concerns about bias in selection of the reported result (e.g. reporting of only a subset of measurements, analysis methods or subsets of the data that were pre-specified). Review authors often specified in the risk of bias tables the study outcomes that were not reported (84 % of studies) but less frequently specified the outcomes that were partially reported (61 % of studies). At least one study was rated at high risk of outcome non-reporting bias in 31 % of reviews. In the random sample of these reviews, only 30 % incorporated this information when interpreting results, by acknowledging that the synthesis of an outcome was missing data that were not/partially reported.ConclusionsOur audit of user practice in Cochrane reviews suggests that the assessment of selective reporting in the current risk of bias tool does not work well. It is not always clear which outcomes were selectively reported or what the corresponding risk of bias is in the synthesis with missing outcome data. New tools that will make it easier for reviewers to convey this information are being developed.Electronic supplementary materialThe online version of this article (doi:10.1186/s13643-016-0289-2) contains supplementary material, which is available to authorized users.

Highlights

  • Selective reporting is included as a core domain of Cochrane’s tool for assessing risk of bias in randomised trials

  • Data source All Cochrane reviews are prepared as RevMan files [13] which are stored in Archie, a database managed by the Cochrane Informatics and Knowledge Management Department (IKMD)

  • Reviews included a median of eight studies (IQR 4–16), and addressed a wide range of topics, with 50 Cochrane Review Groups contributing at least one review to the sample

Read more

Summary

Introduction

Selective reporting is included as a core domain of Cochrane’s tool for assessing risk of bias in randomised trials. Given the frequency with which both types of selective reporting occur [4, 6, 7], authors of systematic reviews are encouraged to assess these sources of bias in the included studies. Selective reporting is included as one of the core domains of the Cochrane tool for assessing the risk of bias in randomised trials (RoB tool) [8]. These criteria include examples of outcome non-reporting bias and bias in selection of the reported result

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.